Maypro Industries and CALPIS Co., Ltd. have announced that they have signed an agreement appointing Maypro to be the U.S. distributor of AmealPeptide®, CALPIS’s patented clinically proven ingredient for healthy blood pressure.
Derived from enzymatically hydrolyzed casein, AmealPeptide® is a naturally- occurring ACE inhibitor backed by 14 double-blind, placebo-controlled studies.
It is the only complete lactotripeptide, containing both the VPP and IPP peptides.
“We are very proud to add AmealPeptide® to our select portfolio of proprietary branded ingredients” said Steve Yamada, Maypro’s CEO. “It is an honor for us to represent one of Japan’s leading beverage companies and to offer a product supported by such an extensive body of clinical research.”
“We are very glad to have this new partnership with Maypro. Maypro is an
excellent company in cultivating proprietary branded ingredients. Through Maypro’s
distribution network, we hope more people will get a chance to take AmealPeptide® so that we contribute to the improvement of everyone’s QOL” said Shunsuke Fuji, Senior Officer, Calpis CO., Ltd.
For additional information on AmealPeptide®, please Maypro online at http://www.maypro.com/
About Calpis
Since 1917, CALPIS Co., Ltd. has manufactured and sold fermented and cultured milk-based products. Calpis’ innovative microbiological technology is in the forefront of scientific achievement in lactic-acid fermentation processing and has secured its leading position in the global marketplace. Calpis is well known in Asia as a soft drink brand, and in recent years its AmealPeptide®-based health drinks and dietary supplements have made their mark on the burgeoning functional foods market in Japan, Europe and the U.S. For more information, please visit www.calpis.net.
About Maypro Industries
Founded in 1977, Maypro is a privately held, global supplier of nutraceutical ingredients to the nutritional supplement, sports nutrition, pet & veterinary, cosmetic, functional food and fine chemical industries and is a minority-owned affiliate of Marubeni Corporation, one of Japan’s largest conglomerates with over $100 billion in annual revenues. Headquartered in Purchase, NY, and with offices in Tokyo and Shanghai, Maypro represents some of the world’s most reputable nutraceutical ingredient manufacturers and supplies high-quality ingredients in the U.S., Japan, Europe, Latin America and Asia. Please visit www.maypro.com or call (914) 251-0701.
